|
Volumn 32, Issue 1, 2002, Pages 122-127
|
Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture
|
Author keywords
Dendritic cell; IL 2; Melanoma; Tyrosinase related protein 2; Vaccination
|
Indexed keywords
INTERLEUKIN 2;
RECOMBINANT INTERLEUKIN 2;
TYROSINASE RELATED PROTEIN 2;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIGEN PRESENTING CELL;
ARTICLE;
BONE MARROW CELL;
CANCER CELL CULTURE;
CELL SPECIFICITY;
CELLULAR IMMUNITY;
CONTROLLED STUDY;
CYTOTOXICITY TEST;
DENDRITIC CELL;
EPIDERMIS CELL;
FETAL CALF SERUM;
FIBROBLAST;
IMMUNE RESPONSE;
LANGERHANS CELL;
LUNG METASTASIS;
MELANOMA;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SKIN METASTASIS;
T LYMPHOCYTE;
TARGET CELL;
TUMOR GROWTH;
TUMOR IMMUNITY;
TUMOR REGRESSION;
TUMOR VOLUME;
VACCINATION;
ANIMALS;
ANTIGENS, NEOPLASM;
BONE MARROW CELLS;
CULTURE MEDIA, SERUM-FREE;
DENDRITIC CELLS;
IMMUNOTHERAPY;
INTERLEUKIN-2;
INTRAMOLECULAR OXIDOREDUCTASES;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
NEOPLASM METASTASIS;
PEPTIDES;
SERUM ALBUMIN, BOVINE;
TUMOR CELLS, CULTURED;
|
EID: 0036147899
PISSN: 00142980
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO;2-C Document Type: Article |
Times cited : (37)
|
References (32)
|